{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:33:46Z","timestamp":1767969226915,"version":"3.49.0"},"reference-count":25,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":399,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,29]]},"abstract":"<jats:p>Peritonitis is still a major cause of the death in peritoneal dialysis (PD) patients despite the significant decline of the peritonitis rates in recent years. The present study is designed to evaluate the therapeutic potential of peroxisome proliferator-activated receptor-\u03b3 agonist, rosiglitazone, on the structure and function of the peritoneum in a PD rat accompanied with peritonitis induced by lipopolysaccharide (LPS). Our data showed that the peritoneal membrane in the LPS-only group showed increased peritoneal thickness, vessel density, and hypercellularity compared with the PD-only group. Rosiglitazone administration significantly inhibited increase of the three indicators in PD rats with LPS treatment. In line with this, rosiglitazone improved function of the peritoneum in LPS-induced PD rats receiving rosiglitazone, which was reflected by decreased D\/P urea and D\/P albumin. Mechanistically, rosiglitazone-mediated improvements in the damaged structure and function of the peritoneum in PD rats with LPS treatment were associated with reduced inflammation and preserving mesothelial cell monolayer resulted from up-regulation of AQP-1 and ZO-1. Our findings thus suggest that peroxisome proliferator-activated receptor \u03b3 (PPAR-\u03b3) activation might be a reasonable strategy to prevent and ameliorate peritoneal deterioration in PD patients, especially with peritonitis.<\/jats:p>","DOI":"10.1042\/bsr20180009","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T15:30:58Z","timestamp":1528212658000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["PPAR-\u03b3 agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1"],"prefix":"10.1042","volume":"38","author":[{"given":"Yunfang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shili","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huadu District People\u2019s Hospital, Southern Medical University, 22# Baohua Road, Huadu District, Guangzhou 510800, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"2021111618594253600_B1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jcpt.12318","article-title":"Preserving the peritoneal membrane in long-term peritoneal dialysis patients","volume":"40","author":"Ditsawanon","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"2021111618594253600_B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3747\/pdi.2014.00086","article-title":"Diagnostic dilemma of ultrafiltration failure in a continuous ambulatory peritoneal dialysis patient","volume":"35","author":"Yuvaraj","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000368972","article-title":"Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach","volume":"39","author":"Teitelbaum","year":"2015","journal-title":"Blood Purif."},{"key":"2021111618594253600_B4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021111618594253600_B5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphys.2014.00412","article-title":"Membrane nanotubes between peritoneal mesothelial cells: functional connectivity and crucial participation during inflammatory reactions","volume":"5","author":"Ranzinger","year":"2014","journal-title":"Front. Physiol."},{"key":"2021111618594253600_B6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MNH.0000000000000151","article-title":"Water and solute transport across the peritoneal membrane","volume":"24","author":"Morelle","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021111618594253600_B7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/pr800916s","article-title":"Stress responses and conditioning effects in mesothelial cells exposed to peritoneal dialysis fluid","volume":"8","author":"Kratochwill","year":"2009","journal-title":"J. Proteome Res."},{"key":"2021111618594253600_B8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3747\/pdi.2009.00206","article-title":"Peritoneal dialysis fluid induces p38-dependent inflammation in human mesothelial cells","volume":"31","author":"Riesenhuber","year":"2011","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3747\/pdi.2014.00211","article-title":"Peritoneal dialysis catheter increases leukocyte recruitment in the mouse parietal peritoneum microcirculation and causes fibrosis","volume":"36","author":"Kowalewska","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"2021111618594253600_B12","doi-asserted-by":"publisher","first-page":"25609","DOI":"10.1074\/jbc.M115.673046","article-title":"A novel peroxisome proliferator-activated receptor (PPAR) \u03b3 agonist 2-hydroxyethyl 5-chloro-4, 5-didehydrojasmonate exerts anti-inflammatory effects in colitis","volume":"290","author":"Choo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"2021111618594253600_B13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1440-1797.2006.00654.x","article-title":"Troglitazone inhibits synthesis of transforming growth factor-\u03b21 and reduces matrix production in human peritoneal mesothelial cells","volume":"11","author":"Peng","year":"2006","journal-title":"Nephrology"},{"key":"2021111618594253600_B14","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s10753-015-0193-2","article-title":"Rosiglitazone, a peroxisome proliferator-activated receptor (PPAR)-\u03b3 agonist, attenuates inflammation via NF-\u03baB inhibition in lipopolysaccharide-induced peritonitis","volume":"38","author":"Zhang","year":"2015","journal-title":"Inflammation"},{"key":"2021111618594253600_B15","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3892\/mmr.2017.6196","article-title":"PPAR-\u03b3 agonist rosiglitazone protects rat peritoneal mesothelial cells against peritoneal dialysis solution-induced damage","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"2021111618594253600_B16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1681\/ASN.V72198","article-title":"Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes","volume":"7","author":"Group","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021111618594253600_B17","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.2011121135","article-title":"Recent peritonitis associates with mortality among patients treated with peritoneal dialysis","volume":"23","author":"Boudville","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021111618594253600_B18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-94-011-0814-0_2","article-title":"Ultrastructure and pathology of the peritoneum in peritoneal dialysis","volume-title":"The Textbook of Peritoneal Dialysis","author":"Dobbie","year":"1994"},{"key":"2021111618594253600_B20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/089686088900900206","article-title":"Loss of ultrafiltration in continuous ambulatory peritoneal dialysis (CAPD)","volume":"9","author":"Pollock","year":"1989","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ki.1983.101","article-title":"Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury","volume":"23","author":"Verger","year":"1983","journal-title":"Kidney Int."},{"key":"2021111618594253600_B22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1440-1797.2008.01037.x","article-title":"Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model","volume":"14","author":"Song","year":"2009","journal-title":"Nephrology"},{"key":"2021111618594253600_B23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3747\/pdi.2010.00032","article-title":"Aquaporin-1: new developments and perspectives for peritoneal dialysis","volume":"30","author":"Devuyst","year":"2010","journal-title":"Perit. Dial. Int."},{"key":"2021111618594253600_B24","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/sj.ki.5000285","article-title":"Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis","volume":"69","author":"Ni","year":"2006","journal-title":"Kidney Int."},{"key":"2021111618594253600_B25","doi-asserted-by":"publisher","first-page":"G851","DOI":"10.1152\/ajpgi.2000.279.5.G851","article-title":"Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells","volume":"279","author":"Nusrat","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180009\/808398\/bsr-2018-0009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180009\/808398\/bsr-2018-0009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:42:49Z","timestamp":1637091769000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/38\/3\/BSR20180009\/57923\/PPAR-agonist-rosiglitazone-ameliorates-peritoneal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6,29]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20180009","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]},"article-number":"BSR20180009"}}